medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2015, Number 617

<< Back Next >>

Rev Med Cos Cen 2015; 72 (617)

Glaucoma una vista al pasado con un futuro prometedor

Maroto JP

Language: Spanish
References: 15
Page: 741-744
PDF size: 160.11 Kb.


ABSTRACT

Glaucoma is an ocular disease characterized by the loss of retinal ganglion cells and their axons. The increase in the intraocular pressure has been synonymous of glaucoma in the past. The next article is a bibliographic review where it shows its definition, classification, diagnosis and treatment. At the end it shows the before and after of glaucoma.


REFERENCES

  1. Anwar, Z., Wellik, S. R., & Galor, A. (2013). Glaucoma therapy and ocular surface disease: current literature and recommendations. Current Opinion in Ophthalmology, 24(2), 136-143. http://doi.org/10.1097/ICU.0b013e32835c8aba

  2. Bettin, P., & Di Matteo, F. (2013). Glaucoma: present challenges and future trends. Ophthalmic Research, 50(4), 197-208. http://doi. org/10.1159/000348736

  3. Caprioli, J. (2013). Glaucoma: a disease of early cellular senescence. Investigative Ophthalmology & Visual Science, 54(14), ORSF60-67. http://doi.org/10.1167/iovs.13-12716

  4. Casson, R. J., Chidlow, G., Wood, J. P. M., Crowston, J. G., & Goldberg, I. (2012). Definition of glaucoma: clinical and experimental concepts. Clinical & Experimental Ophthalmology, 40(4), 341-349. http://doi.org/10.1111/j.1442-9071.2012.02773.x

  5. Coleman, A. L. (2012). Advances in glaucoma treatment and management: surgery. Investigative Ophthalmology & Visual Science, 53(5), 2491-2494. http://doi.org/10.1167/iovs.12-9483l

  6. Garway-Heath, D. F., Crabb, D. P., Bunce, C., Lascaratos, G., Amalfitano, F., Anand, N., … Zeyen, T. G. (2014). Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. http://doi.org/10.1016/S0140-6736 (14) 62111-5

  7. Gessesse, G. W., & Damji, K. F. (2013). Advanced glaucoma: management pearls. Middle East African Journal of Ophthalmology, 20(2), 131-141. http://doi.org/10.4103/0974-9233.110610

  8. Grewal, D. S., & Tanna, A. P. (2013). Diagnosis of glaucoma and detection of glaucoma progression using spectral domain optical coherence tomography. Current Opinion in Ophthalmology, 24(2), 150-161. http://doi.org/10.1097/ICU.0b013e32835d9e27

  9. Heijl, A. (2014). Glaucoma treatment: by the highest level of evidence. Lancet. http://doi.org/10.1016/S0140-6736 (14) 62347-3

  10. Hitchings, R. A. (2009). Glaucoma: an area of darkness. Eye (London, England), 23(9), 1764-1774. http://doi.org/10.1038/eye.2008.260

  11. King, A., Azuara-Blanco, A., & Tuulonen, A. (2013). Glaucoma. BMJ (Clinical Research Ed.), 346, f3518.

  12. McManus, J. R., & Netland, P. A. (2013). Screening for glaucoma: rationale and strategies. Current Opinion in Ophthalmology, 24(2), 144-149. http://doi.org/10.1097/ICU.0b013e32835cf078

  13. Momont, A. C., & Mills, R. P. (2013). Glaucoma screening: current perspectives and future directions. Seminars in Ophthalmology, 28(3), 185-190. http://doi.org/10.3109/08820538.2013.771200

  14. Vohra, R., Tsai, J. C., & Kolko, M. (2013). The role of inflammation in the pathogenesis of glaucoma. Survey of Ophthalmology, 58(4), 311-320. http://doi.org/10.1016/j.survophthal.2012.08.010

  15. Weinreb, R. N., Aung, T., & Medeiros, F. A. (2014). The pathophysiology and treatment of glaucoma: a review. JAMA, 311(18), 1901-1911. http://doi.org/10.1001/jama.2014.3192




2020     |     www.medigraphic.com